Chondrocytes apoptosis in osteoarthritis
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2018, Vol 72, Issue
Abstract
Osteoarthritis (OA) is a type of degenerative joint disease where the balance between the degradation and the regeneration of articular cartilage is impaired, which leads to its progressive loss. This disease is the most common chronic musculoskeletal disease that leads to premature motor disability. Risk factors for developing OA include age, obesity, sex, past traumas and arthritis, genetic factors, diet and ethnicity. Typical OA symptoms are arthralgia, restriction of movement, cracking and secondary inflammatory lesions. In recent years, the underlying causes of this disease include chondrocyte death by apoptosis, necrosis or combinations of these types of cell death. Apoptosis, called programmed cell death, has clear morphological features, and is a highly regulated process. Apoptosis is involved in maintaining homeostasis; however, its severity is observed in many pathological conditions. Articular cartilage chondrocyte death by apoptosis disrupts the proper maintenance of cartilage structure by reducing cell density. Chondrocyte apoptosis causes mechanical damage, manifested by increased synthesis of free oxygen radicals and disturbance of the integrity of the extracellular matrix. An increasing amount of reports regarding the potential pharmacological substances that have been used as inhibitors of apoptosis have improved the quality of life in OA patients. This article presents the current state of knowledge on apoptosis and apoptotic death of chondrocytes in the course of osteoarthritis.<br/><br/>
Authors and Affiliations
Sabina Galiniak, Izabela Krawczyk-Marć, Agata Wawrzyniak, Stanisław Orkisz
Keywords
Related Articles
- EP ID EP396678
- DOI 10.5604/01.3001.0012.6453
- Views 187
- Downloads 0
Wpływ owocystatyny na funkcje poznawcze szczurów
Wstęp: Increased occurrence of cognitive deficits in mild cognitive impairment is related with the phenomenon of aging within the population. Cystatin C has been associated with cysteine protease inhibiting properties as...
PARP inhibitors – theoretical basis and clinical application
Poly-ADP-ribose polymerases (PARP) are involved in a number of processes that are vital for every living cell. Once activated by the presence of DNA damage they trigger poly-ADP-ribosylation of various proteins which ar...
Inhibitors of microtubule polymerization- new natural compounds as potential anti-cancer drugs
Inhibitors of microtubule polymerization are compounds which, by binding to the tubulin dimer, prevent the normal course of cell division and lead to cell death. They cause inhibition of mitosis, affect the cytoskeleton...
AMP-activated protein kinase (AMPK) as therapeutic target
AMP-activated protein kinase (AMPK) is one of the major energy sensor at both: cellular and whole body level. It exists as heterotrimer containing three subunits: the catalytic α subunit, β and regulatory γ. AMPK is loca...
Searching for Tourette’s syndrome gene. Part 2. Patient’s genome variability
Gilles de la Tourette syndrome (GTS) is a complex, heterozygous genetic disorder. Twenty chromosomal rearrangements (7q22-q31, 8q13-q22, and 18q22) indicating genomic regions which may be involved in the etiology of the...